Final - October 19-20, 2022

PRESIDER/PRESENTER(s)

Dr. Grace Lee (ACIP Chair)

Dr. Melinda Wharton (ACIP Executive Secretary, CDC)

9:00 Pneumococcal Vaccines

Introduction

Cost-effectiveness analysis of PCV20 use among adults who 

previously received PCV13

Summary of work group interpretation of EtR and proposed 

recommendations

Dr. Kathy Poehling (ACIP, WG Chair)

Dr. Charles Stoecker (Tulane University)

Dr. Miwako Kobayashi (CDC/NCIRD)

11:00 Break

11:15 Chikungunya Vaccines

Introduction

Overview of chikungunya and chikungunya vaccines

Vaccine immunogenicity and safety

Work group interpretation of vaccine data and activities

Dr. Beth Bell (ACIP, WG Chair)

Dr. Susan Hills (CDC/NCEZID)

Dr. Katrin Dubischar (Valneva)

Dr. Susan Hills (CDC/NCEZID)

12:15 Break

1:15 COVID-19 Vaccines

Introduction

COVID-19 in pregnant people and infants ages 0-5 months

COVID-19 vaccine safety in pregnancy

Effectiv

 

eness of maternal COVID-19 vaccination in pregnant 

COVID-19 vaccines in children

Vaccines for Children

Dr. Matt Daley (ACIP, WG Chair)

Dr. Sascha Ellington (CDC/NCCDPHP)

Dr. Christine Olson (CDC/NCEZID), Dr. Elyse Kharbanda 

(HealthPartners Institute)

Dr. Katherine Fleming-Dutra (CDC/NCIRD)

Dr. Sara Oliver (CDC/NCIRD)

Dr. Jeanne Santoli (CDC/NCIRD)

3:15 Break

3:30 Public Comment

3:50 Votes

Pneumococcal Vaccine

COVID Vaccine (VFC)

Dr. Miwako Kobayashi (CDC/NCIRD)

Dr. Jeanne Santoli (CDC/NCIRD)

4:20 Break

4:30 Polio Vaccines

Poliovirus and Vaccination Dr. Kathleen Dooling (CDC/NCIRD)

5:00 Adjourn

Dr. Grace Lee (ACIP Chair)

Dr. Melinda Wharton (ACIP Executive Secretary, CDC)

8:45 Agency Updates

9:00 Combined Immunization Schedule

Introduction

2023 child and adolescent schedule revisions

2023 adult schedule revisions

Dr. Sybil Cineas (ACIP, WG Chair)

Dr. Patricia Wodi (CDC/NCIRD)

Dr. Neil Murthy (CDC/NCIRD)

10:20 Break

10:30 Respiratory Syncytial Virus Vaccines - Older Adults

Introduction

GSK safety & efficacy

Pfizer safety & efficacy

WG considerations

Dr. Camille Kotton (ACIP, WG Chair)

Dr. Bishoy Rizkalla (GSK)

Dr. Alejandra Gurtman (Pfizer) 

Dr. Michael Melgar (CDC/NCIRD)

11:40 Respiratory Syncytial Virus Vaccines - Maternal/Pediatric

Introduction

Nirsevimab updated safety and efficacy

WG considerations

Dr. Sarah Long (ACIP, WG Chair)

Dr. Christian Felter (Sanofi)

Dr. Jefferson Jones (CDC/NCIRD)

12:10 Break

Wednesday, October 19, 2022

8:30 Welcome & Introductions

Thursday, October 20, 2022

8:30 Welcome & Introductions

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

Centers for Disease Control and Prevention

AGENDA ITEM

Atlanta, Georgia 30329 

October 19-20, 2022

page 1 of 2
Final - October 19-20, 2022

1:00 Public Comment

1:20 Vote(s)

Immunization Schedules Dr. Patricia Wodi (CDC/NCIRD)

Dr. Neil Murthy (CDC/NCIRD)

1:30 Meningococcal Vaccines

Introduction

Menveo Solution updates 

Terms of reference for pentavalent vaccines

Dr. Kathy Poehling (ACIP, WG Chair)

Dr. Sam Crowe (CDC/NCIRD)

Dr. Sam Crowe (CDC/NCIRD)

1:55 Break

2:10 Influenza Vaccines

Introduction

Clinical Trial to Compare Safety of RIV4 Versus IIV4 in Pregnancy	

Influenza Activity Update

Influenza Vaccine Effectiveness Update	

Dr. Keipp Talbot (ACIP, WG Chair)

Dr. Geeta Swamy (Duke University)

Ms. Lynnette Brammer and Dr. Perrine Marcenac 

(CDC/NCIRD)

Ms. Jessie Chung, Ms. Samantha Olson, and Dr. Nathaniel 

Lewis (CDC/NCIRD)

3:10 Dengue Vaccines

Introduction

Dengue Epidemiology

Review of Sanofi dengue vaccine and ACIP recommendations

Dr. Wilbur Chen (ACIP, WG Chair)

Dr. Laura Adams (CDC/NCEZID)

Dr. Gabriela Paz-Bailey (CDC/NCEZID) 

3:45 Monkeypox Vaccines

Introduction Dr. Pablo Sanchez (ACIP, Chair)

4:00 Adjourn

Acronyms

CDC Centers for Disease Control and Prevention

CMS Centers for Medicare and Medicaid Services 

COVID- Coronavirus disease 2019

EtR Evidence to Recommendations Framework

FDA Food and Drug Administration

GRAD

E

HRSA Health Resources and Services Administration

IHS Indian Health Service

NCHH

NCIRD

NCEZI National Center for Emerging and Zoonotic Diseases [of CDC/OID]

NIAID National Institute of Allergy and Infectious Diseases

OIDP Office of Infectious Disease and HIV/AIDS Policy

SARSCoV-2Severe acute respiratory syndrome coronavirus 2

WG Work Group

WHO World Health Organization

VE Vaccine Effectiveness

Grading of Recommendations Assessment, Development and Evaluation

National Center for HIV, Hepatitis, STD and TB Prevention [of CDC/OID] 

National Center for Immunization & Respiratory Diseases [of CDC/OID] 

page 2 of 2